We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

79 hedge funds and large institutions have $249M invested in VanEck Biotech ETF in 2017 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 21 increasing their positions, 23 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

223% more call options, than puts

Call options by funds: $4.94M | Put options by funds: $1.53M

12% more capital invested

Capital invested by funds: $222M → $249M (+$26.6M)

9% less repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 23

5% less funds holding

Funds holding: 83 → 79 (-4)

18.06% less ownership

Funds ownership: 52.71% → 34.65% (-18%)

33% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 9

Holders
79
Holders Change
-4
Holders Change %
-4.82%
% of All Funds
1.97%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
21
Reduced
23
Closed
9
Calls
$4.94M
Puts
$1.53M
Net Calls
+$3.41M
Net Calls Change
-$1.44M

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$14.1M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$2.31M
3
RJA
Raymond James & Associates
Florida
+$1.62M
4
CCA
Conservest Capital Advisors
Pennsylvania
+$1.33M
5
IA
IFP Advisors
Florida
+$241K

Top Sellers

Rank Fund Capital Flow
1
Nomura Asset Management
Nomura Asset Management
Japan
-$1.76M
2
ZIM
Zacks Investment Management
Illinois
-$1.12M
3
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors
Iowa
-$1.04M
4
ECM
Endurant Capital Management
California
-$938K
5
TBA
Train Babcock Advisors
New York
-$782K
Name Holding Trade Value Shares
Change 		Change in
Stake
Janney Montgomery Scott
26
Janney Montgomery Scott
Pennsylvania
$968K -$133K -1,025 -12%
ClearBridge Investments
27
ClearBridge Investments
New York
$939K -$3.26K -25 -0.4%
GJIC
28
Gamble Jones Investment Counsel
California
$805K – – –
Bank of New York Mellon
29
Bank of New York Mellon
New York
$778K +$39.1K +300 +5%
IA
30
IFP Advisors
Florida
$756K +$241K +1,851 +49%
WJA
31
Williams Jones & Associates
New York
$735K – – –
Wells Fargo
32
Wells Fargo
California
$665K -$69.4K -533 -10%
LTFS
33
Ladenburg Thalmann Financial Services
Florida
$645K +$38.8K +298 +7%
MJRIC
34
Mogy Joel R Investment Counsel
California
$616K +$224K +1,720 +60%
CAN
35
Cetera Advisor Networks
California
$579K +$1.82K +14 +0.3%
SBH
36
Segall Bryant & Hamill
Illinois
$577K – – –
RJFSA
37
Raymond James Financial Services Advisors
Florida
$576K +$49.9K +383 +10%
BPC
38
Banque Pictet & Cie
Switzerland
$503K – – –
IAMOG
39
Investors Asset Management of Georgia
Georgia
$496K – – –
VWA
40
V Wealth Advisors
Kansas
$448K – – –
First Manhattan
41
First Manhattan
New York
$402K – – –
MML Investors Services
42
MML Investors Services
Massachusetts
$379K -$13.8K -106 -4%
AB
43
Atlas Brown
Kentucky
$360K -$11.5K -88 -3%
TCM
44
Tufton Capital Management
Maryland
$355K – – –
SC
45
Scotia Capital
Ontario, Canada
$317K -$90.5K -695 -23%
Jane Street
46
Jane Street
New York
$300K -$391 -3 -0.1%
SWP
47
Stratos Wealth Partners
Ohio
$296K +$15.2K +117 +6%
B
48
Bailard
California
$290K +$17.6K +135 +7%
PNC Financial Services Group
49
PNC Financial Services Group
Pennsylvania
$289K – – –
SG Americas Securities
50
SG Americas Securities
New York
$235K – – –
1
2
3 4

BBH Hedge Fund Activity: Q3 2017 in Review

79 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q3 2017, worth a combined $249M — up 12% from $222M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of BBH and 6 opened new positions — a net loss of 3 holders — while 23 trimmed existing stakes and 21 added.

The largest buyer was UBS Group, adding an estimated $14.1M. The largest seller was Nomura Asset Management, exiting entirely with an estimated $1.76M sold.

  • 79 institutional investors held VanEck Biotech ETF (BBH) as of Q3 2017, down from 83 in Q2 2017.
  • Funds reported $249M of VanEck Biotech ETF stock for Q3 2017, up 12% quarter-over-quarter.
  • 6 funds opened new VanEck Biotech ETF positions in Q3 2017 and 9 closed out, a net change of -3 holders.
  • The largest VanEck Biotech ETF buyer in Q3 2017 was UBS Group, an estimated $14.1M added.
  • The largest VanEck Biotech ETF seller in Q3 2017 was Nomura Asset Management, an estimated $1.76M sold.

Based on aggregated 13F filings for Q3 2017.